Indoco Remedies Limited — Updates, 24-07-2025: Press Release

Indoco Remedies has secured EU Good Manufacturing Practices (GMP) Compliance for its sterile drug product manufacturing facility, Goa Plant II, from European Health Authorities. This key operational update confirms the plant meets stringent European quality benchmarks, vital for continued market access and sales in the region. This certification underscores Indoco's robust manufacturing capabilities and commitment to delivering high-quality, affordable medicines globally, potentially bolstering investor confidence and strengthening its international footprint.